tiprankstipranks
Arcturus Therapeutics (ARCT)
NASDAQ:ARCT
US Market

Arcturus Therapeutics (ARCT) Income Statement

Compare
1,604 Followers

Arcturus Therapeutics Income Statement

Last quarter (Q4 2024), Arcturus Therapeutics's total revenue was $21.00M, a decrease of -25.56% from the same quarter last year. In Q4, Arcturus Therapeutics's net income was $-30.00M. See Arcturus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 152.31M$ 157.75M$ 205.75M$ 12.36M$ 9.54M
Gross Profit
$ 152.31M$ 154.79M$ 62.70M$ -159.50M$ -46.41M
Operating Expenses
$ 247.98M$ 235.95M$ 193.58M$ 215.21M$ 81.06M
Depreciation and Amortization
$ 3.54M$ 2.96M$ 1.53M$ 1.19M$ 882.00K
EBITDA
$ -77.40M$ -24.17M$ 13.70M$ -201.66M$ -70.64M
Operating Income
$ -95.67M$ -78.20M$ 12.18M$ -202.85M$ -71.52M
Other Income/Expenses
$ 14.72M$ 50.31M$ -1.53M$ -822.00K$ -624.00K
Pretax Income
$ -80.94M$ -27.89M$ 10.64M$ -203.67M$ -72.15M
Net Income
$ -80.94M$ -29.73M$ 9.35M$ -206.86M$ -71.36M
Per Share Metrics
Basic EPS
$ -3.00$ -1.12$ 0.35$ -7.86$ -3.51
Diluted EPS
$ -3.00$ -1.12$ 0.35$ -7.86$ -3.51
Weighted Average Shares Outstanding
27.00M 26.63M 26.45M 26.32M 20.30M
Weighted Average Shares Outstanding (Diluted)
27.00M 26.63M 27.09M 26.32M 20.30M
Currency in USD

Arcturus Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis